Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy

M. Hiligsmann, S. Maggi, N. Veronese, L. Sartori, J.Y. Reginster

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)595-606
Number of pages12
JournalOsteoporosis International
Issue number3
Publication statusPublished - 1 Mar 2021


  • alendronate
  • buffered soluble alendronate
  • cost-effectiveness
  • economic evaluation
  • effervescent tablets
  • osteoporosis
  • treatment
  • Alendronate
  • Effervescent tablets
  • Osteoporosis
  • Treatment
  • Economic evaluation
  • Cost-effectiveness
  • Buffered soluble alendronate

Cite this